Clinical Trial Update: Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial comparing GNR-060 to Metalyse in ST Elevation Myocardial Infarction is in early/unknown status to evaluate efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• GNR-060
• Metalyse (tenecteplase)

Snippet

Sponsor: AO GENERIUM | Conditions: ST Elevation Myocardial Infarction | Phase 3 | Status: UNKNOWN